Virulent Mycobacterium fortuitum restricts NO production by a gamma interferon-activated J774 cell line and phagosome-lysosome fusion

Infection and Immunity

Volumn 70, Issue 10, 2002, Pages 5628-5634

  Marques da Silva, Tânia Regina ^a   De Freitas, Juliana Ribeiro ^a   Chagas Silva, Queilan ^a   Pereira Figueira, Cláudio ^a   Roxo, Eliana ^a   Cardoso Leão, Sylvia ^a   Rodrigues de Freitas, Luiz Antônio ^a   Tavares Veras, Patrícia Sampaio ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

BOVINE SERUM ALBUMIN; COLLOIDAL GOLD; GAMMA INTERFERON; N ACETYL S NITROSOPENICILLAMINE; NITRIC OXIDE; NITROGEN DERIVATIVE; RADICAL;

ANIMAL CELL; ARTICLE; BACTERIAL VIRULENCE; BACTERIUM COLONY; BACTERIUM ISOLATE; CELL ACTIVATION; CELL FUSION; CELL LABELING; CELL LINE; CONTROLLED STUDY; CORRELATION ANALYSIS; HOST RESISTANCE; LYSOSOME; MACROPHAGE; MYCOBACTERIUM FORTUITUM; NONHUMAN; PHAGOSOME; PRIORITY JOURNAL;

ANIMALS; CELL LINE; INTERFERON-GAMMA, RECOMBINANT; LYSOSOMES; MACROPHAGE ACTIVATION; MACROPHAGES; MEMBRANE FUSION; MICE; MICROSCOPY, ELECTRON; MYCOBACTERIUM FORTUITUM; NITRIC OXIDE; PHAGOSOMES; VARIATION (GENETICS); VIRULENCE;

EID: 0036785684     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.70.10.5628-5634.2002     Document Type: Article

References (43)

1. L-arginine-dependent macrophage effector functions inhibit metabolic activity of Mycobacterium leprae
2. Effector mechanisms involved in cytokine-mediated bacteriostasis of Mycobacterium avium infections in murine macrophages
3. Tumour necrosis factor-alpha (TNF-α) in the host resistance to mycobacteria of distinct virulence
4. Differential trafficking of live and dead Mycobacterium marinum organisms in macrophages
5. Differential mechanisms of intracellular killing of Mycobacterium avium and Listeria monocytogenes by activated human and murine macrophages: The role of nitric oxide
6. Killing of virulent Mycobacterium tuberculosis by reactive nitrogen intermediates produced by activated murine macrophages
7. Characterization of the Mycobacterium tuberculosis phagosome and evidence that phagosomal maturation is inhibited
8. Preliminary demonstration of human tuberculoimmunity in vitro
9. Comparison of 15 laboratory and patient-derived strains of Mycobacterium avium for ability to infect and multiply in cultured human macrophages
10. Interferon-gamma-treated murine macrophages inhibit growth of tubercle bacilli via the generation of reactive nitrogen intermediates
11. Maturation of phagosomes is accompanied by changes in their fusion properties and size-selective acquisition of solute materials from endosomes
12. A novel antioxidant gene from Mycobacterium tuberculosis
13. Growth inhibition of Mycobacterium bovis by IFN-γ stimulated macrophages: Regulation by endogenous tumor necrosis factor-alpha and by IL-10
14. The phagosomal environment protects virulent Mycobacterium avium from killing and destruction by clarithromycin
15. Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids
16. Clinical features of pulmonary disease caused by rapidly growing mycobacteria: An analysis of 154 patients
17. Rapidly growing mycobacterial lung infection in association with esophageal disorders
18. Mycobacterium fortuitum bacteremia in patients with cancer and long-term venous catheters
19. Requirement for transcription factor IRF-1 in NO synthase induction in macrophages
20. Role of interferon regulatory factor 1 in induction of nitric oxide synthase
21. Characterization and growth in human macrophages of Mycobacterium avium complex strains isolated from the blood of patients with acquired immunodeficiency syndrome
22. Differential release of interleukin (IL)-1α, IL-1β, and IL-6 from normal human monocytes stimulated with a virulent and an avirulent isogenic variant of Mycobacterium avium-intracellulare complex
23. Relationship of colonial morphology to virulence for chickens of Mycobacterium avium and the nonphotochromogens
24. Cell-mediated immune response
25. Growth rate of mycobacteria in mice as an unreliable indicator of mycobacterial virulence
26. Comparable growth of virulent and avirulent Mycobacterium tuberculosis in human macrophages in vitro
27. Characterization of the virulence of Mycobacterium avium complex (MAC) isolates in mice
28. Multiple drug resistance in Mycobacterium avium: Is the wall architecture responsible for exclusion of antimicrobial agents?
29. Activation of macrophages to inhibit proliferation of Mycobacterium tuberculosis: Comparison of the effects of recombinant gamma-interferon on human monocytes and murine peritoneal macrophages
30. Susceptibilities of transparent, opaque, and rough colonial variants of Mycobacterium avium complex to various fatty acids
31. Pathogenicity of transparent, opaque, and rough variants of Mycobacterium avium in chickens and mice
32. Cytokine activation leads to acidification and increases maturation of Mycobacterium avium-containing phagosomes in murine macrophages
33. Differences in mannose receptor-mediated uptake of lipoarabinomannan from virulent and attenuated strains of Mycobacterium tuberculosis by human macrophages
34. Differences in antimicrobial susceptibility of pigmented and unpigmented colonial variants of Mycobacterium avium
35. Lack of acidification in Mycobacterium phagosomes produced by exclusion of the vesicular proton-ATPase
36. Rapid identification of mycobacteria to the species level by polymerase chain reaction and restriction enzyme analysis
37. Activation of the mitogen-activated protein kinase signaling pathway is instrumental in determining the ability of Mycobacterium avium to grow in murine macrophages
38. Effects of cytokines on mycobacterial phagosome maturation
39. + T cells is sufficient to mediate T helper cell type 1 development
40. Diagnosis and treatment of disease caused by nontuberculous mycobacteria. Official statement of the American Thoracic Society, March 1997
41. Hairy cell leukemia: Association with disseminated atypical mycobacterial infection
42. Nontuberculous mycobacteria and associated diseases
43. Intracellular trafficking in Mycobacterium tuberculosis and Mycobacterium avium-infected macrophages